ATE107504T1 - Arzneimittel zur behandlung von kryptosporidiose. - Google Patents

Arzneimittel zur behandlung von kryptosporidiose.

Info

Publication number
ATE107504T1
ATE107504T1 AT89912649T AT89912649T ATE107504T1 AT E107504 T1 ATE107504 T1 AT E107504T1 AT 89912649 T AT89912649 T AT 89912649T AT 89912649 T AT89912649 T AT 89912649T AT E107504 T1 ATE107504 T1 AT E107504T1
Authority
AT
Austria
Prior art keywords
cryptosporidiosis
treatment
prophylaxis
animal
medications
Prior art date
Application number
AT89912649T
Other languages
English (en)
Inventor
Victoria Susan Latter
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE107504T1 publication Critical patent/ATE107504T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT89912649T 1989-10-16 1989-10-26 Arzneimittel zur behandlung von kryptosporidiose. ATE107504T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898923254A GB8923254D0 (en) 1989-10-16 1989-10-16 Medicaments

Publications (1)

Publication Number Publication Date
ATE107504T1 true ATE107504T1 (de) 1994-07-15

Family

ID=10664644

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89912649T ATE107504T1 (de) 1989-10-16 1989-10-26 Arzneimittel zur behandlung von kryptosporidiose.

Country Status (14)

Country Link
EP (1) EP0496729B1 (de)
JP (1) JPH05502435A (de)
KR (1) KR920703038A (de)
AT (1) ATE107504T1 (de)
AU (1) AU637772B2 (de)
CA (1) CA2001566A1 (de)
DE (1) DE68916443T2 (de)
DK (1) DK50092D0 (de)
GB (1) GB8923254D0 (de)
HU (1) HU208625B (de)
IE (1) IE893450A1 (de)
MC (1) MC2203A1 (de)
WO (1) WO1991005550A1 (de)
ZA (1) ZA898143B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9126874D0 (en) * 1991-12-18 1992-02-19 Wellcome Found Medicaments
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
GB9613309D0 (en) * 1996-06-25 1996-08-28 Univ Sheffield Quinone bacterial inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents

Also Published As

Publication number Publication date
DE68916443T2 (de) 1994-12-22
AU4519289A (en) 1991-05-16
AU637772B2 (en) 1993-06-10
EP0496729B1 (de) 1994-06-22
EP0496729A1 (de) 1992-08-05
CA2001566A1 (en) 1991-04-16
KR920703038A (ko) 1992-12-17
DK50092A (da) 1992-04-14
ZA898143B (en) 1991-06-26
MC2203A1 (fr) 1992-11-26
HU9201295D0 (en) 1992-07-28
IE893450A1 (en) 1991-04-24
JPH05502435A (ja) 1993-04-28
GB8923254D0 (en) 1989-12-06
DE68916443D1 (de) 1994-07-28
HUT60431A (en) 1992-09-28
WO1991005550A1 (en) 1991-05-02
DK50092D0 (da) 1992-04-14
HU208625B (en) 1993-12-28

Similar Documents

Publication Publication Date Title
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE69602412T2 (de) Ophthalmische Zubereitung zur Behandlung oder Prävention von trockenem Auge und Krankheiten, die dadurch verursacht werden, enthaltend 12-Sulfodehydroabietsäure
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
RU2001118854A (ru) Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний
DE68916651T2 (de) Heilmittel zur behandlung von toxoplasmose.
ATE107504T1 (de) Arzneimittel zur behandlung von kryptosporidiose.
RU98101105A (ru) Новое применение в медицинских целях
ATE190484T1 (de) Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
DE69312297T2 (de) Verwendung von 2-[4-(-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphtoquinon zur behandlung von krebs
GEP19970834B (en) 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
RU93052444A (ru) Лекарственный препарат бан
DE60113895D1 (de) Verwendung von Tiludronsäure beim Geflügel zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Osteoporose
KR890000089A (ko) 신장 질환 치료제

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties